PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Total Stockholders Equity : $1,452 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk Total Stockholders Equity?

PT Kalbe Farma Tbk's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $1,452 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PT Kalbe Farma Tbk's Book Value per Share for the quarter that ended in Mar. 2024 was $6.28. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PT Kalbe Farma Tbk's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.03.

PT Kalbe Farma Tbk Total Stockholders Equity Historical Data

The historical data trend for PT Kalbe Farma Tbk's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Total Stockholders Equity Chart

PT Kalbe Farma Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,143.31

1,234.00

1,372.17

1,295.86

1,389.39

PT Kalbe Farma Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															1,407.54	1,338.30	1,331.67	1,389.39	1,451.85

PT Kalbe Farma Tbk (OTCPK:PTKFY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PT Kalbe Farma Tbk's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1451.846	-	0)	/	231.278
	=	6.28

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PT Kalbe Farma Tbk's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.179	+	27.12)	/	1451.846
	=	0.03

PT Kalbe Farma Tbk Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PTKFF:USA KLBF:Indonesia

Address

Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510

Website

https://www.kalbe.co.id

Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Headlines

No Headlines